A child is examined by a doctor

Key facts

AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company.

Our mission is to make a meaningful difference to patient health through great medicines that bring benefit for patients and add value for our stakeholders and society.

We discover, develop, manufacture and market prescription medicines for six important areas of healthcare, which include some of the world’s most serious illnesses: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.

We also work with others to combine complementary skills and strengthen the platform for success in meeting a common goal: improved healthcare.

We are active in over 100 countries with a growing presence in emerging markets including China, Brazil, Mexico and Russia.

We employ over 57,200 people (46% in Europe, 31% in the Americas and 23% in Asia-Pacific).

We invest over $4 billion in R&D each year. About 11,300 work in our R&D organisation, we have 14 principal R&D centres in eight countries, and 9,600 employees work at our Supply & Manufacturing sites in 16 countries.

Annual Report 2011

AstraZeneca Annual Report 2011

Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to meet complex healthcare challenges and make a meaningful difference for patients worldwide.